Design of Nanoparticles in Cancer Therapy Based on Tumor Microenvironment Properties

被引:11
作者
Firouzabadi, Bita Mahdavi [1 ]
Gigliobianco, Maria Rosa [2 ]
Joseph, Joice Maria [1 ]
Censi, Roberta [1 ]
Di Martino, Piera [1 ,3 ]
机构
[1] Univ Camerino, Sch Pharm, CHiP Chem Interdisciplinary Project, Via Madonna Carceri, I-62032 Camerino, Italy
[2] Percuros BV, Zernikedreef 8, NL-2333 CL Leiden, Netherlands
[3] Univ G DAnnunzio Chieti & Pescara, Dipartimento Farm, Via Vestini 1, I-66100 Chieti, Italy
基金
欧盟地平线“2020”;
关键词
tumor microenvironment; nano-systems; nanoparticles; cancer therapy; HYPOXIA-RESPONSIVE NANOPARTICLES; TARGETED DRUG-DELIVERY; GROWTH-FACTOR; MATRIX METALLOPROTEINASES; ENHANCED PERMEABILITY; EXTRACELLULAR-MATRIX; MANNOSE; 6-PHOSPHATE; CELL UPTAKE; PH; MACROPHAGES;
D O I
10.3390/pharmaceutics14122708
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cancer is one of the leading causes of death worldwide, and battling cancer has always been a challenging subject in medical sciences. All over the world, scientists from different fields of study try to gain a deeper knowledge about the biology and roots of cancer and, consequently, provide better strategies to fight against it. During the past few decades, nanoparticles (NPs) have attracted much attention for the delivery of therapeutic and diagnostic agents with high efficiency and reduced side effects in cancer treatment. Targeted and stimuli-sensitive nanoparticles have been widely studied for cancer therapy in recent years, and many more studies are ongoing. This review aims to provide a broad view of different nanoparticle systems with characteristics that allow them to target diverse properties of the tumor microenvironment (TME) from nanoparticles that can be activated and release their cargo due to the specific characteristics of the TME (such as low pH, redox, and hypoxia) to nanoparticles that can target different cellular and molecular targets of the present cell and molecules in the TME.
引用
收藏
页数:39
相关论文
共 204 条
[1]   Hybrid Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Modulating Tumor Hypoxia [J].
Abbasi, Azhar Z. ;
Gordijo, Claudia R. ;
Amini, Mohammad Ali ;
Maeda, Azusa ;
Rauth, Andrew M. ;
DaCosta, Ralph S. ;
Wu, Xiao Yu .
CANCER RESEARCH, 2016, 76 (22) :6643-6656
[2]   Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer [J].
Aggarwal S. ;
Gupta S. ;
Pabla D. ;
Murthy R.S.R. .
Cancer Nanotechnology, 2013, 4 (6) :145-157
[3]   Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity [J].
Albini, Adriana ;
Bruno, Antonino ;
Gallo, Cristina ;
Pajardi, Giorgio ;
Noonan, Douglas M. ;
Dallaglio, Katiuscia .
CONNECTIVE TISSUE RESEARCH, 2015, 56 (05) :414-425
[4]   Factors affecting the clearance and biodistribution of polymeric nanoparticles [J].
Alexis, Frank ;
Pridgen, Eric ;
Molnar, Linda K. ;
Farokhzad, Omid C. .
MOLECULAR PHARMACEUTICS, 2008, 5 (04) :505-515
[5]   Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling [J].
Allen, Elizabeth ;
Mieville, Pascal ;
Warren, Carmen M. ;
Saghafinia, Sadegh ;
Li, Leanne ;
Peng, Mei-Wen ;
Hanahan, Douglas .
CELL REPORTS, 2016, 15 (06) :1144-1160
[6]   From Krebs to clinic: glutamine metabolism to cancer therapy [J].
Altman, Brian J. ;
Stine, Zachary E. ;
Dang, Chi V. .
NATURE REVIEWS CANCER, 2016, 16 (10) :619-634
[7]   Nuclear Localizing Peptide-Conjugated, Redox-Sensitive Polymersomes for Delivering Curcumin and Doxorubicin to Pancreatic Cancer Microtumors [J].
Anajafi, Tayebeh ;
Yu, Junru ;
Sedigh, Abbas ;
Haldar, Manas K. ;
Muhonen, Wallace W. ;
Oberlander, Seth ;
Wasness, Heather ;
Froberg, Jamie ;
Molla, Shahjahan ;
Katti, Kalpana S. ;
Choi, Yongki ;
Shabb, John B. ;
Srivastava, D. K. ;
Mallik, Sanku .
MOLECULAR PHARMACEUTICS, 2017, 14 (06) :1916-1928
[8]   A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy [J].
Ayati, Adileh ;
Moghimi, Setareh ;
Salarinejad, Somayeh ;
Safavi, Maliheh ;
Pouramiri, Behjat ;
Foroumadi, Alireza .
BIOORGANIC CHEMISTRY, 2020, 99
[9]   The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside [J].
Azevedo-Silva, J. ;
Queiros, O. ;
Baltazar, F. ;
Uaszewski, S. ;
Goffeau, A. ;
Ko, Y. H. ;
Pedersen, P. L. ;
Preto, A. ;
Casal, M. .
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2016, 48 (04) :349-362
[10]   Nanoparticles and targeted drug delivery in cancer therapy [J].
Bahrami, Behdokht ;
Hojjat-Farsangi, Mohammad ;
Mohammadi, Hamed ;
Anvari, Enayat ;
Ghalamfarsa, Ghasem ;
Yousefi, Mehdi ;
Jadidi-Niaragh, Farhad .
IMMUNOLOGY LETTERS, 2017, 190 :64-83